Clinical Trials
21 trialsNCT04410367 2025-07-20
PURSUE
Blue Earth Diagnostics
Phase 2 Completed
NCT04535414 2025-01-17
Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04775602 2025-01-09
F-PSMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT01190787 2024-01-23
Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone
European Myeloma Network B.V.
Phase 2 Completed
NCT01160107 2023-06-29
RP_MPR
Fondazione EMN Italy Onlus
Phase 2 Completed
NCT00128856 2023-03-06
Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients
Spanish Breast Cancer Research Group
Phase 2 Completed
NCT02798406 2021-07-15
CAPTIVE
DNAtrix, Inc.
Phase 2 Completed
NCT03648879 2021-07-12
Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01613300 2021-05-26
Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2 Completed
NCT03755947 2021-02-02
Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia
Grupo Cooperativo de Hemopatías Malignas
Phase 2 Completed
NCT01262027 2019-07-30
TKI258 for Metastatic Inflammatory Breast Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02971319 2018-01-26
Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma
Proactina S.A.
Phase 2 Completed
NCT00788892 2018-01-12
Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Jazz Pharmaceuticals
Phase 2 Completed
NCT00332969 2017-03-31
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Novartis
Phase 2 Completed
NCT01620359 2016-08-31
Study of ExAblate Focused Ultrasound Ablation of Breast Cancer
InSightec
Phase 2 Completed
NCT02468050 2015-06-10
Study of Exercise to Manage Distress During Breast Screening
University of Western Ontario, Canada
Phase 2 Completed
NCT00284141 2012-12-10
Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma
Sanofi
Phase 2 Completed
NCT00784849 2012-06-20
Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)
Louisiana State University Health Sciences Center in New Orleans
Phase 2 Completed
NCT00224601 2011-02-18
CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT00571675 2010-11-09
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Ascenta Therapeutics
Phase 2 Completed
NCT00143975 2010-08-12
Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)
University of Ulm
Phase 2 Completed